scholarly journals Donor Derived Cell Free DNA as a Risk Factor for Initiating De-Novo Donor Specific Antibodies in Heart Transplantation

2021 ◽  
Vol 40 (4) ◽  
pp. S217-S218
Author(s):  
E.C. DePasquale ◽  
J. Kobashigawa ◽  
S. Hall ◽  
T. Wolf-Doty ◽  
J. Teuteberg ◽  
...  
Keyword(s):  
Risk Factor ◽  
Heart Transplantation ◽  
De Novo ◽  
Cell Free Dna ◽  
Specific Antibodies ◽  
Free Dna ◽  
Donor Specific Antibodies

scholarly journals DD-CFDNA AS A RISK FACTOR FOR INITIATING DE-NOVO DONOR SPECIFIC ANTIBODIES IN HEART TRANSPLANTATION

2020 ◽  
Vol 104 (S3) ◽  
pp. S131-S132
Author(s):  
Eugene Depasquale ◽  
Jon Kobashigawa ◽  
Sean Pinney ◽  
Jeffrey Teuteberg ◽  
Kiran Khush
Keyword(s):  
Risk Factor ◽  
Heart Transplantation ◽  
De Novo ◽  
Specific Antibodies ◽  
Donor Specific Antibodies

Does Cell-Free DNA Detect the Development of De Novo Donor Specific Antibodies

2019 ◽  
Vol 38 (4) ◽  
pp. S288 ◽  
Author(s):  
J.A. Kobashigawa ◽  
J. Patel ◽  
E. Kransdorf ◽  
D. Chang ◽  
M. Kittleson ◽  
...  
Keyword(s):  
De Novo ◽  
Cell Free Dna ◽  
Specific Antibodies ◽  
Free Dna ◽  
Donor Specific Antibodies

De novo DQ donor-specific antibodies are associated with worse outcomes compared to non-DQ de novo donor-specific antibodies following heart transplantation

2017 ◽  
Vol 31 (4) ◽  
pp. e12924 ◽  
Author(s):  
Robert Townsend Cole ◽  
Jonathan Gandhi ◽  
Robert A. Bray ◽  
Howard M. Gebel ◽  
Alanna Morris ◽  
...  
Keyword(s):  
Heart Transplantation ◽  
De Novo ◽  
Specific Antibodies ◽  
Donor Specific Antibodies
Sign in / Sign up

Export Citation Format

Share Document